These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34118395)

  • 41. Head-to-head comparison of tau positron emission tomography tracers [
    Smith R; Schöll M; Leuzy A; Jögi J; Ohlsson T; Strandberg O; Hansson O
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):342-354. PubMed ID: 31612245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multimodal cross-examination of progressive apraxia of speech by diffusion tensor imaging-based tractography and Tau-PET scans.
    Gatto RG; Pham NTT; Duffy JR; Clark HM; Utianski RL; Botha H; Machulda MM; Lowe VJ; Schwarz CG; Jack CR; Josephs KA; Whitwell JL
    Hum Brain Mapp; 2024 Jun; 45(8):e26704. PubMed ID: 38825988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of spill-in counts from off-target regions on [
    López-González FJ; Costoya-Sánchez A; Paredes-Pacheco J; Moscoso A; Silva-Rodríguez J; Aguiar P;
    Neuroimage; 2022 Oct; 259():119396. PubMed ID: 35753593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [
    Risacher SL; Farlow MR; Bateman DR; Epperson F; Tallman EF; Richardson R; Murrell JR; Unverzagt FW; Apostolova LG; Bonnin JM; Ghetti B; Saykin AJ
    Acta Neuropathol Commun; 2018 Oct; 6(1):114. PubMed ID: 30373672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
    Devous MD; Fleisher AS; Pontecorvo MJ; Lu M; Siderowf A; Navitsky M; Kennedy I; Southekal S; Harris TS; Mintun MA
    J Alzheimers Dis; 2021; 80(3):1091-1104. PubMed ID: 33682705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of
    Sur C; Adamczuk K; Scott D; Kost J; Sampat M; Buckley C; Farrar G; Newton B; Suhy J; Bennacef I; Egan MF
    Mol Imaging Biol; 2022 Dec; 24(6):862-873. PubMed ID: 35794343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal flortaucipir, metabolism and volume differ between phonetic and prosodic speech apraxia.
    Tetzloff KA; Martin PR; Duffy JR; Utianski RL; Clark HM; Botha H; Machulda MM; Thu Pham NT; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Brain; 2024 May; 147(5):1696-1709. PubMed ID: 38217867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tau-related white-matter alterations along spatially selective pathways.
    Wen Q; Risacher SL; Xie L; Li J; Harezlak J; Farlow MR; Unverzagt FW; Gao S; Apostolova LG; Saykin AJ; Wu YC
    Neuroimage; 2021 Feb; 226():117560. PubMed ID: 33189932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.
    Buckley RF; Mormino EC; Rabin JS; Hohman TJ; Landau S; Hanseeuw BJ; Jacobs HIL; Papp KV; Amariglio RE; Properzi MJ; Schultz AP; Kirn D; Scott MR; Hedden T; Farrell M; Price J; Chhatwal J; Rentz DM; Villemagne VL; Johnson KA; Sperling RA
    JAMA Neurol; 2019 May; 76(5):542-551. PubMed ID: 30715078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of [
    Lowe VJ; Lundt E; Knopman D; Senjem ML; Gunter JL; Schwarz CG; Kemp BJ; Jack CR; Petersen RC
    Neuroimage Clin; 2017; 16():295-302. PubMed ID: 28856092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females.
    Edwards L; La Joie R; Iaccarino L; Strom A; Baker SL; Casaletto KB; Cobigo Y; Grant H; Kim M; Kramer JH; Mellinger TJ; Pham J; Possin KL; Rosen HJ; Soleimani-Meigooni DN; Wolf A; Miller BL; Rabinovici GD
    Neurobiol Aging; 2021 Sep; 105():86-98. PubMed ID: 34049062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between long-term donepezil treatment and brain regional amyloid and tau burden among individuals with mild cognitive impairment assessed using
    Li J; Zheng C; Ge Q; Yan S; Paranjpe MD; Hu S; Zhou Y;
    J Neurosci Res; 2022 Feb; 100(2):670-680. PubMed ID: 34882830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.
    Colato E; Chiotis K; Ferreira D; Mazrina MS; Lemoine L; Mohanty R; Westman E; Nordberg A; Rodriguez-Vieitez E;
    J Alzheimers Dis; 2021; 84(1):103-117. PubMed ID: 34511502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
    Ossenkoppele R; Rabinovici GD; Smith R; Cho H; Schöll M; Strandberg O; Palmqvist S; Mattsson N; Janelidze S; Santillo A; Ohlsson T; Jögi J; Tsai R; La Joie R; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; Choi JY; Ryu YH; Lyoo CH; Hansson O
    JAMA; 2018 Sep; 320(11):1151-1162. PubMed ID: 30326496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer's disease.
    Biel D; Luan Y; Brendel M; Hager P; Dewenter A; Moscoso A; Otero Svaldi D; Higgins IA; Pontecorvo M; Römer S; Steward A; Rubinski A; Zheng L; Schöll M; Shcherbinin S; Ewers M; Franzmeier N;
    Alzheimers Res Ther; 2022 Nov; 14(1):166. PubMed ID: 36345046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of
    La Joie R; Visani AV; Lesman-Segev OH; Baker SL; Edwards L; Iaccarino L; Soleimani-Meigooni DN; Mellinger T; Janabi M; Miller ZA; Perry DC; Pham J; Strom A; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Neurology; 2021 Feb; 96(5):e650-e661. PubMed ID: 33262228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.
    Cho H; Choi JY; Lee HS; Lee JH; Ryu YH; Lee MS; Jack CR; Lyoo CH
    J Nucl Med; 2019 Nov; 60(11):1611-1621. PubMed ID: 30926651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.